# The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

> **NCT02660242** · PHASE2 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** G-Pen Mini™ (glucagon injection)
- **OTHER:** Glucose Tabs
- **OTHER:** Basal Insulin Reduction

## Key facts

- **NCT ID:** NCT02660242
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-02-15
- **Final completion:** 2017-02-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660242, "The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02660242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*